Placenta Imaging Project

CompletedOBSERVATIONAL
Enrollment

379

Participants

Timeline

Start Date

October 13, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
High Risk Pregnancy
Interventions
DEVICE

MRI

Recently-developed placenta-specific magnetic resonance imaging (MRI) tools will be used to quantify maternal perfusion and oxygen transfer throughout pregnancy in 3 groups of human subjects: 1) non-smokers, 2) smokers, 3) individuals at high risk for adverse outcome. The objective of this work is to develop a new non-invasive clinical tool for early identification of placental dysfunction.

DEVICE

MRI - IUGR

Recently-developed placenta-specific magnetic resonance imaging (MRI) tools will be used to quantify maternal perfusion and oxygen transfer throughout pregnancy. The objective of this ancillary arm is to further test the sensitivity of placental magnetic resonance imaging to detect abnormal perfusion and oxygenation in confirmed cases of IUGR between gestational ages 28 to 36 weeks.

Trial Locations (2)

84112

University of Utah, Salt Lake City

97239

Oregon Health and Science University, Portland

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Oregon Health and Science University

OTHER

NCT02749851 - Placenta Imaging Project | Biotech Hunter | Biotech Hunter